A detailed history of Rbf Capital, LLC transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Rbf Capital, LLC holds 63,857 shares of OMGA stock, worth $51,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,857
Previous 66,257 3.62%
Holding current value
$51,724
Previous $137,000 43.8%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.22 - $2.25 $2,928 - $5,400
-2,400 Reduced 3.62%
63,857 $77,000
Q4 2023

Feb 14, 2024

SELL
$1.35 - $3.21 $5,053 - $12,015
-3,743 Reduced 5.35%
66,257 $199,000
Q1 2023

May 16, 2023

SELL
$4.81 - $10.95 $35,146 - $80,011
-7,307 Reduced 9.45%
70,000 $422,000
Q2 2022

Aug 15, 2022

BUY
$2.01 - $7.19 $155,387 - $555,837
77,307 New
77,307 $294,000

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $38.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Rbf Capital, LLC Portfolio

Follow Rbf Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbf Capital, LLC with notifications on news.